Low measles seropositivity rate among children and young adults: A sero-epidemiological study in southern China in 2008

Vaccine

Volumn 28, Issue 51, 2010, Pages 8219-8223

  Fu, Chuanxi ^a,b   Xu, Jianxiong ^b   Liu, Weibin ^c   Zhang, Wei ^b   Wang, Ming ^b   Nie, Jun ^a   Rüdiger, von Kries ^d  

^a SOUTHERN MEDICAL UNIVERSITY   (China)

^b GUANGZHOU CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^c Mayo Clinic College of Medicine   (United States)

^d UNIVERSITY OF MUNICH   (Germany)

Author keywords

Immunity; Measles; Seroprevalence

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; MEASLES ANTIBODY; MEASLES VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; CATCH UP VACCINATION; CHILD; CHINA; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GROUPS BY AGE; HEALTH PROMOTION; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MEASLES; MEASLES VACCINATION; NEWBORN; PREGNANCY; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROEPIDEMIOLOGY; SEROPREVALENCE; STATISTICAL DISTRIBUTION;

ADOLESCENT; ADULT; AGE FACTORS; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MEASLES; MIDDLE AGED; SEROEPIDEMIOLOGIC STUDIES; YOUNG ADULT;

EID: 78649673829     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.07.071     Document Type: Article

References (30)

1. WHO-UNICEF joint statement on strategies to reduce measles mortality worldwide. Wkly Epidemiol Rec 2002, 77(27):224-228.
2. Perry R.T., Halsey N.A. The clinical significance of measles: a review. J Infect Dis 2004, 189(Suppl. 1):S4-S16.
3. Duke T., Mgone C.S. Measles: not just another viral exanthem. Lancet 2003, 361(9359):763-773.
4. Muscat M., Bang H., Wohlfahrt J., Glismann S., Molbak K. Measles in Europe: an epidemiological assessment. Lancet 2009, 373(9661):383-389.
5. Campbell H., Andrews N., Brown K.E., Miller E. Review of the effect of measles vaccination on the epidemiology of SSPE. Int J Epidemiol 2007, 36(6):1334-1348.
6. Ma C., Luo H., An Z., Zhang P., Wen N., Xia W., et al. Analysis on epidemiological characteristics and measures of measles control in China during 2006-2007. Chinese J. Vacc. Immunization 2008, 14(3):208-213. [in Chinese].
7. Lixia W., Guang Z., Lee L.A., Zhiwei Y., Jingjin Y., Jun Z., et al. Progress in accelerated measles control in the People's Republic of China, 1991-2000. J Infect Dis 2003, 187(Suppl. 1):S252-S257.
8. Yu X., Wang S., Guan J., Mahemuti, Purhati, Gou A., et al. Analysis of the cause of increased measles incidence in Xinjiang, China in 2004. Pediatr Infect Dis J 2007, 26(6):513-518. [in Chinese].
9. Progress toward the 2012 measles elimination goal-Western Pacific Region, 1990-2008. MMWR Morb Mortal Wkly Rep 2009, 58(24):669-673.
10. Xu J., Liang J., Tan H., Yun X. Epidemiological characteristics and control measures of measles in Guangzhou city during 2002-2005. J Trop Med 2007, 7(7):699-701. [in Chinese].
11. McFarland J.W., Mansoor O.D., Yang B. Accelerated measles control in the Western Pacific region. J Infect Dis 2003, 187(Suppl. 1):S246-S251.
12. Chuang S.K., Lau Y.L., Lim W.L., Chow C.B., Tsang T., Tse L.Y. Mass measles immunization campaign: experience in the Hong Kong Special Administrative Region of China. Bull World Health Organ 2002, 80(7):585-591.
13. Mao N., Jiang X., Wu L., Nan L., Xu W. Comparative study on application of quantitative ELISA for detection of measles antibody. Chin J Vacc Immunization 2005, 11(3):187-189. [in Chinese].
14. Kim S.S., Han H.W., Go U., Chung H.W. Sero-epidemiology of measles and mumps in Korea: impact of the catch-up campaign on measles immunity. Vaccine 2004, 23(3):290-297.
15. Fu C., Wang M., Liang J., He T., Wang D., Xu J. Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study. Vaccine 2007, 25(52):8756-8761.
16. Liang X., Bi S., Yang W., Wang L., Cui G., Cui F., et al. Evaluation of the impact of hepatitis B vaccination among children born during 1992-2005 in China. J Infect Dis 2009, 200(1):39-47.
17. Cui F.Q., Gofin R. Immunization coverage and its determinants in children aged 12-23 months in Gansu, China. Vaccine 2007, 25(4):664-671.
18. Wang L., Li J., Chen H., Li F., Armstrong G.L., Nelson C., et al. Hepatitis B vaccination of newborn infants in rural China: evaluation of a village-based, out-of-cold-chain delivery strategy. Bull World Health Organ 2007, 85(9):688-694.
19. Liang J., Yuan J., Wang D. Analysis of EPI outpatients in Guangzhou. South China J Prev Med 2004, 30(2):37-39. [in Chinese].
20. Wood J.G., Gidding H.F., Heywood A., Macartney K., McIntyre P.B., Macintyre C.R. Potential impacts of schedule changes, waning immunity and vaccine uptake on measles elimination in Australia. Vaccine 2009, 27(2):313-318.
21. Kremer J.R., Schneider F., Muller C.P. Waning antibodies in measles and rubella vaccinees-a longitudinal study. Vaccine 2006, 24(14):2594-2601.
22. Rota M.C., Massari M., Gabutti G., Guido M., De Donno A., Ciofi D.A.M. Measles serological survey in the Italian population: interpretation of results using mixture model. Vaccine 2008, 26(34):4403-4409.
23. Velicko I., Muller L.L., Pebody R., Gergonne B., Aidyralieva C., Kostiuchenko N., et al. Nationwide measles epidemic in Ukraine: the effect of low vaccine effectiveness. Vaccine 2008, 26(52):6980-6985.
24. Richard J.L., Spicher V.M. Ongoing measles outbreak in Switzerland: results from November 2006 to July 2007. Euro Surveill 2007, 12(7):E70721-E70726.
25. Bernard H., Fischer R., Wild F. Ongoing measles outbreak in southern Bavaria, Germany. Euro Surveill 2008, 13(1).
26. Wichmann O., Siedler A., Sagebiel D., Hellenbrand W., Santibanez S., Mankertz A., et al. Further efforts needed to achieve measles elimination in Germany: results of an outbreak investigation. Bull World Health Organ 2009, 87(2):108-115.
27. Watson-Creed G., Saunders A., Scott J., Lowe L., Pettipas J., Hatchette T.F. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. CMAJ 2006, 175(5):483-488.
28. Pichichero M.E. Booster vaccinations: can immunologic memory outpace disease pathogenesis?. Pediatrics 2009, 124(6):1633-1641.
29. Xu G.Z., Ma R., Xu H.J., Ma Y.H., Dong H.J., Li Y., et al. Levels of transition on maternal transferred measles antibody in infants in 3 cities in China. Zhonghua Liu Xing Bing Xue Za Zhi 2008, 29(11):1074-1077. [in Chinese].
30. Cilla G., Serrano-Bengoechea E., Vicente D., Montes M., Perez-Trallero E. Robustness of measles immunity in parturient women in Gipuzkoa, Basque Country, Spain, in the post-vaccination era. Euro Surveill 2007, 12(9):E9-E10.